Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Other financing activities (2021 - 2024)

Historic Other financing activities for Evoke Pharma (EVOK) over the last 3 years, with Q4 2024 value amounting to -$1.0.

  • Evoke Pharma's Other financing activities changed N/A to -$1.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $426292.0, marking a year-over-year change of. This contributed to the annual value of $426292.0 for FY2024, which is 25733.97% up from last year.
  • Per Evoke Pharma's latest filing, its Other financing activities stood at -$1.0 for Q4 2024.
  • In the past 5 years, Evoke Pharma's Other financing activities registered a high of $426292.0 during Q1 2024, and its lowest value of -$1.0 during Q4 2024.
  • Its 3-year average for Other financing activities is $115631.6, with a median of $6421.0 in 2021.